Abstract
Generation of the reactive oxygen species (ROS) in skin by exposure to ultraviolet (UV) radiation induces a number of cutaneous pathologies such as skin cancer, photosensitization, and photoaging among others. Skin iron catalyzes UV generation of ROS. Topical application of iron chelators reduces erythema, epidermal and dermal hypertrophy, wrinkle formation, tumour appearance. It has been proposed that iron chelators can be useful agents against damaging effects of both short- and long-term UV exposure. A better understanding of the action mechanisms of iron chelators, might be useful to developing effective anticancer and antiphotoaging cosmetic products. Iron chelators may lead to accumulation of protoporphyrin IX (PpIX), a strong photosensitizer. The action of iron chelators in skin, related to PpIX increase has not yet been thoroughly studied. Therefore, we have investigated the formation of PpIX in normal mouse skin after topical application of creams containing metal chelators. The amount and distribution of porphyrins formed was determined by means of non-invasive fluorescence spectroscopy. Deferoxamine (DF), ethylenediaminetetraacetic acid (EDTA), 1,2-diethyl-3-hydroxypyridin-4-one (CP94), but not meso-2,3-dimercaptosuccinic acid (DMSA), caused increased accumulation of endogenous porphyrins in the skin. Fluorescence excitation and emission spectroscopy confirmed that PpIX was the main fluorescent species. The amount of PpIX accumulated in skin under the present conditions was not large enough to produce any significant erythema after light exposure. Further studies are needed to evaluate the role of PpIX induced by iron chelators used, against photoaging and cancer prevention.
Similar content being viewed by others
References
H. S. Black, Potential involvement of free radical reactions in ultraviolet light-mediated cutaneous damage, Photochem. Photobiol., 1987, 46, 213–221.
A. Svobodova, D. Walterova, J. Vostalova, Ultraviolet light induced alteration to the skin, Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 2006, 150, 25–38.
C. Pourzand, R. D. Watkin, J. E. Brown, R. M. Tyrrell, Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: the role of ferritin, Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 6751–6756.
M. Kruszewski, Labile iron pool: the main determinant of cellular response to oxidative stress, Mutat. Res., 2003, 531, 81–92.
P. Brenneisen, J. Wenk, L. O. Klotz, M. Wlaschek, K. Briviba, T. Krieg, H. Sies, K. Scharffetter-Kochanek, Central role of ferrous/ferric iron in the ultraviolet B irradiation-mediated signaling pathway leading to increased interstitial collagenase (matrix-degrading metalloprotease (MMP)-1) and stromelysin-1 (MMP-3) mRNA levels in cultured human dermal fibroblasts, J. Biol. Chem., 1998, 273, 5279–5287.
M. Kitazawa, K. Iwasaki, Reduction of ultraviolet light-induced oxidative stress by amino acid–based iron chelators, Biochim. Biophys. Acta, 1999, 1473, 400–408.
B. A. Jurkiewicz, G. R. Buettner, Ultraviolet light-induced free radical formation in skin: an electron paramagnetic resonance study, Photochem. Photobiol., 1994, 59, 1–4.
B. A. Jurkiewicz, G. R. Buettner, EPR detection of free radicals in UV-irradiated skin: mouse versus human, Photochem. Photobiol., 1996, 64, 918–922.
D. L. Bissett, D. M. Oelrich, D. P. Hannon, Evaluation of a topical iron chelator in animals and in human beings: short-term photoprotection by 2-furildioxime, J. Am. Acad. Dermatol., 1994, 31, 572–578.
D. L. Bissett, R. Chatterjee, D. P. Hannon, Chronic ultraviolet radiation-induced increase in skin iron and the photoprotective effect of topically applied iron chelators, Photochem. Photobiol., 1991, 54, 215–223.
H. Mitani, I. Koshiishi, T. Sumita, T. Imanari, Prevention of the photodamage in the hairless mouse dorsal skin by kojic acid as an iron chelator, Eur. J. Pharmacol., 2001, 411, 169–174.
D. L. Bissett, J. F. McBride, Synergistic topical photoprotection by a combination of the iron chelator 2-furildioxime and sunscreen, J. Am. Acad. Dermatol., 1996, 35, 546–549.
M. Kitazawa, Y. Ishitsuka, M. Kobayashi, T. Nakano, K. Iwasaki, K. Sakamoto, K. Arakane, T. Suzuki, L. H. Kligman, Protective effects of an antioxidant derived from serine and vitamin B6 on skin photoaging in hairless mice, Photochem. Photobiol., 2005, 81, 970–974.
M. Kitazawa, K. Iwasaki, K. Sakamoto, Iron chelators may help prevent photoaging, J. Cosmet. Dermatol., 2006, 5, 210–217.
I. N. H. White, J. A. White, H. H. Liem, U. Muller-Eberhard, Decreased cytochrome p450 and increased porphyrin concentrations in the livers of rats on a low iron diet given a single dose of desferrioxamine, Biochem. Pharmacol., 1978, 27, 865–870.
P. R. Sinclair, S. Granick, Heme control on the synthesis of delta-aminolevulinic acid synthetase in cultured chick embryo liver cells, Ann. N. Y. Acad. Sci., 1975, 244, 509–520.
A. G. Smith, B. Clothier, J. E. Francis, A. H. Gibbs, M. F. De, R. C. Hider, Protoporphyria induced by the orally active iron chelator 1,2-diethyl-3-hydroxypyridin-4-one in C57BL/10ScSn mice, Blood, 1997, 89, 1045–1051.
M. G. Strakhovskaya, A. O. Shumarina, G. Y. Fraikin, A. B. Rubin, Endogenous porphyrin accumulation and photosensitization in the yeast Saccharomyces cerevisiae in the presence of 2,2’-dipyridyl, J. Photochem. Photobiol., B, 1999, 49, 18–22.
M. G. Strakhovskaya, E. V. Ivanova, O. A. Kolesnikova, G. Y. Fraikin, Effect of 2,2’-dipyridyl on accumulation of protoporphyrin IX and its derivatives in yeast mitochondria and plasma membranes, Biochemistry (Moscow), 1999, 64, 213–216.
P. Juzenas, A. Juzeniene, J. Moan, Deferoxamine photosensitizes cancer cells in vitro, Biochem. Biophys. Res. Commun., 2005, 332, 388–391.
Z. Malik, G. Kostenich, L. Roitman, B. Ehrenberg, A. Orenstein, Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice, J. Photochem. Photobiol., B, 1995, 28, 213–218.
B. Ortel, A. Tanew, H. Honigsmann, Lethal photosensitization by endogenous porphyrins of PAM cells-modification by desferrioxamine, J. Photochem. Photobiol., B, 1993, 17, 273–278.
S. Fijan, H. Honigsmann, B. Ortel, Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine, Br. J. Dermatol., 1995, 133, 282–288.
Y. Ninomiya, Y. Itoh, T. Henta, A. Ishibashi, Photodynamic diagnosis of basal cell carcinoma on the lower eyelid using topical 5-aminolaevulinic acid and desferrioxamine, Br. J. Dermatol., 1999, 141, 580–581.
K. Choudry, R. C. Brooke, W. Farrar, L. E. Rhodes, The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy, Br. J. Dermatol., 2003, 149, 124–130.
A. Curnow, A. J. MacRobert, S. G. Bown, Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid, Lasers Surg. Med., 2006, 38, 325–331.
P. Uehlinger, J. P. Ballini, B. H. van den, G. Wagnieres, On the role of iron and one of its chelating agents in the production of protoporphyrin IX generated by 5-aminolevulinic acid and its hexyl ester derivative tested on an epidermal equivalent of human skin, Photochem. Photobiol., 2006, 82, 1069–1076.
M. Tronchin, G. Jori, M. Neumann, M. Schuetz, A. Saiyadpour, H.-D. Brauer, Sunlight-promoted Photosensitizing and Photophysical Properties of Porphyrins, Internet J. Sci., 1997, 3, C37.
J. L. Domingo, Prevention by chelating agents of metal-induced developmental toxicity, Reprod. Toxicol., 1995, 9, 105–113.
A. L. Miller, Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity, Altern. Med. Rev., 1998, 3, 199–207.
Y. Liu, G. Viau, R. Bissonnette, Multiple large-surface photodynamic therapy sessions with topical or systemic aminolevulinic acid and blue light in UV-exposed hairless mice, J. Cutan. Med Surg., 2004, 8, 131–139.
S. Sharfaei, G. Viau, H. Lui, D. Bouffard, R. Bissonnette, Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice, Br. J. Dermatol., 2001, 144, 1207–1214.
S. Sharfaei, P. Juzenas, J. Moan, R. Bissonnette, Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice, Arch. Dermatol. Res., 2002, 294, 237–242.
I. M. Stender, N. Bech-Thomsen, T. Poulsen, H. C. Wulf, Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice, Photochem. Photobiol., 1997, 66, 493–496.
A. Donfrancesco, G. Deb, S. L. De, R. Cozza, A. Castellano, Role of deferoxamine in tumor therapy, Acta Haematol., 1996, 95, 66–69.
M. Alam, J. S. Dover, Treatment of photoaging with topical aminolevulinic acid and light, Skin Ther. Lett., 2004, 9, 7–9.
J. S. Dover, A. C. Bhatia, B. Stewart, K. A. Arndt, Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging, Arch. Dermatol., 2005, 141, 1247–1252.
M. H. Gold, The evolving role of aminolevulinic acid hydrochloride with photodynamic therapy in photoaging, Cutis, 2002, 69, 8–13.
M. P. Goldman, R. A. Weiss, M. A. Weiss, Intense pulsed light as a nonablative approach to photoaging, Dermatol. Surg., 2005, 31, 1179–1187.
T. M. Busch, Local physiological changes during photodynamic therapy, Lasers Surg. Med., 2006, 38, 494–499.
B. W. Henderson, T. M. Busch, J. W. Snyder, Fluence rate as a modulator of PDT mechanisms, Lasers Surg. Med., 2006, 38, 489–493.
G. Zonios, J. Bykowski, N. Kollias, Skin melanin, hemoglobin, and light scattering properties can be quantitatively assessed in vivo using diffuse reflectance spectroscopy, J. Invest. Dermatol., 2001, 117, 1452–1457.
J. A. Bouwstra, P. L. Honeywell-Nguyen, G. S. Gooris, M. Ponec, Structure of the skin barrier and its modulation by vesicular formulations, Prog. Lipid Res., 2003, 42, 1–36.
J. T. van den Akker, V. Iani, W. M. Star, H. J. Sterenborg, J. Moan, Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum, Photochem. Photobiol., 2000, 72, 681–689.
T. Yano, N. Higo, K. Fukuda, M. Tsuji, K. Noda, M. Otagiri, Further evaluation of a new penetration enhancer, HPE-101, J. Pharm. Pharmacol., 1993, 45, 775–778.
M. Nakashima, M. F. Zhao, H. Ohya, M. Sakurai, H. Sasaki, K. Matsuyama, M. Ichikawa, Evaluation of in vivotransdermal absorption of cyclosporin with absorption enhancer using intradermal microdialysis in rats, J. Pharm. Pharmacol., 1996, 48, 1143–1146.
J. L. Buss, F. M. Torti, S. V. Torti, The role of iron chelation in cancer therapy, Curr. Med. Chem., 2003, 10, 1021–1034.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Juzeniene, A., Juzenas, P., Iani, V. et al. Topical applications of iron chelators in photosensitization. Photochem Photobiol Sci 6, 1268–1274 (2007). https://doi.org/10.1039/b703861e
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/b703861e